KRYS - Krystal Biotech, Inc.
260.33
-4.670 -1.794%
Share volume: 276,507
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$265.00
-4.67
-0.02%
Summary score
11%
Profitability
15%
Dept financing
3%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.75%
Return on assets
-7.79%
Return on sales
0%
Return on invested capital
350.41%
Total debt ratio
24.68%
Debt ratio change over timeo
0%
Current Ratio
46.55%
Quick Ratio
0%
Cash Position Ratio
44.25%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-2.51%
Return on assets
-2.68%
Return on sales
0%
Return on invested capital
-48.7%
Total debt ratio
2.96%
Debt ratio change over timeo
0%
Current Ratio
52.15%
Quick Ratio
0%
Cash Position Ratio
50.25%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-2.21%
Return on assets
-2.19%
Return on sales
0%
Return on invested capital
-49.6%
Total debt ratio
2.66%
Debt ratio change over time
0%
Current Ratio
51.2%
Quick Ratio
0%
Cash Position Ratio
50.02%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KRYS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 18.75% | 11.55% | 5.76% | 8.53% |
| Return on assets | -7.79% | 3.57% | 4.02% | 5.96% |
| Return on sales | 0% | 42.16% | 39.53% | 45.73% |
| Return on invested capital | 350.41% | 7.99% | 5.61% | 8.26% |
| Profitability | 50% | 54% | 47% | 62% |
| Total debt ratio | 24.68% | 74.11% | 65.71% | 48.2% |
| Debt ratio change over time | 0% | 0% | 376.49% | 4.51% |
| Dept financing | 8% | 25% | 47% | 17% |
| Current Ratio | 52.15% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 50.25% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 27% | 25% | 18% |
| Short-term ratios | KRYS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -2.51% | 17.94% | -1.29% | 11.66% |
| Return on assets | -2.68% | 3.67% | 1.51% | 6.9% |
| Return on sales | 0% | 37.5% | 16.39% | 50.72% |
| Return on invested capital | -48.7% | 7.17% | -0.65% | 10.66% |
| Profitability | 0% | 74% | 14% | 91% |
| Total debt ratio | 2.96% | 83.42% | 64.86% | 51.93% |
| Debt ratio change over time | 0% | 0% | 1.76% | 4.05% |
| Dept financing | 1% | 25% | 30% | 41% |
| Current Ratio | 52.15% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 50.25% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 17% | 27% | 17% |